Aehr Test Systems (NASDAQ:AEHR) Upgraded to Strong-Buy at Jefferies Financial Group

Jefferies Financial Group upgraded shares of Aehr Test Systems (NASDAQ:AEHR) to a strong-buy rating in a research note issued to investors on Thursday,Zacks.com reports.

AEHR has been the subject of several other research reports. Weiss Ratings cut shares of Aehr Test Systems from a “sell (d)” rating to a “sell (e+)” rating in a research note on Wednesday, July 29th. Zacks Research raised shares of Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a research note on Friday, July 17th. Wall Street Zen upgraded Aehr Test Systems from a “sell” rating to a “hold” rating in a report on Saturday, July 18th. Craig Hallum restated a “buy” rating and issued a $125.00 price target on shares of Aehr Test Systems in a research report on Wednesday, July 15th. Finally, Lake Street Capital reaffirmed a “buy” rating and issued a $110.00 price target on shares of Aehr Test Systems in a report on Wednesday, July 15th. Three investment analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $136.67.

Aehr Test Systems Stock Up 8.7%

Shares of NASDAQ AEHR opened at $134.06 on Thursday. The firm has a 50-day simple moving average of $92.83 and a 200-day simple moving average of $71.45. The stock has a market capitalization of $4.37 billion, a price-to-earnings ratio of -558.56 and a beta of 3.10. Aehr Test Systems has a 52 week low of $16.38 and a 52 week high of $147.40.

Insider Activity at Aehr Test Systems

In other Aehr Test Systems news, EVP Alberto Salamone sold 9,672 shares of Aehr Test Systems stock in a transaction dated Thursday, August 13th. The shares were sold at an average price of $127.72, for a total transaction of $1,235,307.84. Following the transaction, the executive vice president directly owned 41,962 shares of the company’s stock, valued at $5,359,386.64. The trade was a 18.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Howard T. Slayen sold 20,000 shares of the business’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $108.30, for a total transaction of $2,166,000.00. Following the completion of the transaction, the director owned 146,367 shares in the company, valued at $15,851,546.10. The trade was a 12.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 109,475 shares of company stock valued at $13,827,160 over the last ninety days. Corporate insiders own 6.80% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Royal Bank of Canada grew its position in Aehr Test Systems by 262.7% in the first quarter. Royal Bank of Canada now owns 50,207 shares of the semiconductor company’s stock worth $365,000 after acquiring an additional 36,364 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Aehr Test Systems by 8.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,225 shares of the semiconductor company’s stock worth $126,000 after acquiring an additional 1,344 shares during the last quarter. JPMorgan Chase & Co. raised its position in Aehr Test Systems by 7.9% in the second quarter. JPMorgan Chase & Co. now owns 15,576 shares of the semiconductor company’s stock valued at $201,000 after purchasing an additional 1,145 shares during the period. Legal & General Group Plc raised its position in Aehr Test Systems by 110.8% in the second quarter. Legal & General Group Plc now owns 6,882 shares of the semiconductor company’s stock valued at $89,000 after purchasing an additional 3,617 shares during the period. Finally, Rhumbline Advisers lifted its stake in shares of Aehr Test Systems by 3.1% in the 2nd quarter. Rhumbline Advisers now owns 41,466 shares of the semiconductor company’s stock valued at $536,000 after purchasing an additional 1,254 shares during the last quarter. 69.69% of the stock is currently owned by institutional investors and hedge funds.

Key Headlines Impacting Aehr Test Systems

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems
• Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
• Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity
• Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference
• Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale
• Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation

About Aehr Test Systems

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.